These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24511913)

  • 1. Micturition difficulty and urinary retention associated with aripiprazole and citalopram treatment in a male adolescent with Asperger syndrome.
    Yalcin O
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):598-9. PubMed ID: 24511913
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary obstruction with citalopram and aripiprazole combination in an elderly patient.
    Padala PR; Sadiq HJ; Padala KP
    J Clin Psychopharmacol; 2006 Dec; 26(6):667-8. PubMed ID: 17110829
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.
    Duggal HS; Kithas J
    Am J Psychiatry; 2005 Feb; 162(2):397-8. PubMed ID: 15677611
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole-associated acute dystonia.
    Sanghadia M; Pinninti NR
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):89-90. PubMed ID: 17308239
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin toxicity in aripiprazole augmentation.
    Primeau M; Pomeraniec F; Wallace DM
    J Neuropsychiatry Clin Neurosci; 2012; 24(1):E36-7. PubMed ID: 22450642
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose aripiprazole in the treatment of SSRI-induced bruxism.
    Oulis P; Dimitrakopoulos S; Konstantakopoulos G; Tsaltas E; Kollias K
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E39. PubMed ID: 23037677
    [No Abstract]   [Full Text] [Related]  

  • 7. An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
    Matthews JD; Siefert C; Dording C; Denninger JW; Park L; van Nieuwenhuizen AO; Sklarsky K; Hilliker S; Homberger C; Rooney K; Fava M
    J Clin Psychopharmacol; 2009 Feb; 29(1):73-6. PubMed ID: 19142112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole in a patient susceptible to urinary side effects of antipsychotics.
    Sahoo S
    Isr J Psychiatry Relat Sci; 2007; 44(1):74-5. PubMed ID: 17668467
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.
    Huang LC; Chiang KT
    J Clin Psychopharmacol; 2011 Jun; 31(3):376-7. PubMed ID: 21532363
    [No Abstract]   [Full Text] [Related]  

  • 10. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
    Sarkar R; Klein J; Krüger S
    Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
    [No Abstract]   [Full Text] [Related]  

  • 11. Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI.
    Michael S; Boulton M; Andrews G
    Aust N Z J Psychiatry; 2014 Sep; 48(9):878-9. PubMed ID: 24604919
    [No Abstract]   [Full Text] [Related]  

  • 12. Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
    Cohen ST; Rulf D; Pies R
    J Clin Psychiatry; 2005 Jan; 66(1):135-6. PubMed ID: 15669901
    [No Abstract]   [Full Text] [Related]  

  • 13. Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.
    Werremeyer A
    Am J Psychiatry; 2009 Nov; 166(11):1298. PubMed ID: 19884241
    [No Abstract]   [Full Text] [Related]  

  • 14. Does aripiprazole protect from serotonin syndrome?
    Rittmannsberger H; Werl R
    Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095
    [No Abstract]   [Full Text] [Related]  

  • 15. Micturition difficulty associated with aripiprazole: report of 2 cases.
    Chiang CL; Liu CC
    J Clin Psychopharmacol; 2011 Feb; 31(1):128-9. PubMed ID: 21192159
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
    Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
    J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole associated urine retention in a male schizophrenia patient.
    Hsu WY; Chang TG; Chiu NY
    Gen Hosp Psychiatry; 2013; 35(6):680.e11-2. PubMed ID: 23932666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
    Menza MA; Dobkin RD; Marin H
    J Clin Psychopharmacol; 2007 Apr; 27(2):207-10. PubMed ID: 17414231
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
    Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
    J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potentiation of Aripiprazole extrapiramidal adverse effects with the concomitant use of serotonin selective reuptake inhibitors].
    Miranda C M; Retamal C P
    Rev Med Chil; 2011 Nov; 139(11):1517-8. PubMed ID: 22446662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.